Emma J. De Neef
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Emma J. De Neef has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Alice H. Berger
Department of Genome Sciences, University of Washington, Seattle, WA, USA
1 shared publication - Andrea E. Belleville
Computational Biology Program, Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America
1 shared publication - Austin M. Gabel
Fred Hutchinson Cancer Research Center, Seattle, WA
1 shared publication Emma R. Hoppe
Computational Biology Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, USA
1 shared publicationJacob T. Polaski
Computational Biology Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, USA
1 shared publication- Jacqueline Watson
Proteomics Platform, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
1 shared publication
Latest Publications
- 7 January 2020
- Published by Springer Nature in Nature Genetics
- Vol. 52 (1) , 84-94
RNA isoform screens uncover the essentiality and tumor-suppressor activity of ultraconserved poison exons
While RNA-seq has enabled comprehensive quantification of alternative splicing, no correspondingly high-throughput assay exists for functionally interrogating individual isoforms. We describe pgFARM (paired guide RNAs for alternative exon removal), a CRISPR–Cas9-based method to manipulate isoforms independent of gene inactivation. This approach enabled rapid suppression of exon recognition in polyclonal settings to identify functional roles for individual exons, such as an SMNDC1 cassette exon that regulates pan-cancer intron retention. We generalized this method to a pooled screen to measure the functional relevance of ‘poison’ cassette exons, which disrupt their host genes’ reading frames yet are frequently ultraconserved. Many poison exons were essential for the growth of both cultured cells and lung adenocarcinoma xenografts, while a subset had clinically relevant tumor-suppressor activity. The essentiality and cancer relevance of poison exons are likely to contribute to their unusually high conservation and contrast with the dispensability of other ultraconserved elements for viability.
- 7 January 2020
- Published by Springer Nature in Nature Genetics
- Vol. 52 (1) , 84-94
RNA isoform screens uncover the essentiality and tumor-suppressor activity of ultraconserved poison exons
While RNA-seq has enabled comprehensive quantification of alternative splicing, no correspondingly high-throughput assay exists for functionally interrogating individual isoforms. We describe pgFARM (paired guide RNAs for alternative exon removal), a CRISPR–Cas9-based method to manipulate isoforms independent of gene inactivation. This approach enabled rapid suppression of exon recognition in polyclonal settings to identify functional roles for individual exons, such as an SMNDC1 cassette exon that regulates pan-cancer intron retention. We generalized this method to a pooled screen to measure the functional relevance of ‘poison’ cassette exons, which disrupt their host genes’ reading frames yet are frequently ultraconserved. Many poison exons were essential for the growth of both cultured cells and lung adenocarcinoma xenografts, while a subset had clinically relevant tumor-suppressor activity. The essentiality and cancer relevance of poison exons are likely to contribute to their unusually high conservation and contrast with the dispensability of other ultraconserved elements for viability.